I. B. Lumholtz

发表

Kinetic studies of thyroxine, 3,5,3'-triiodothyronine, 3,3,5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1981, The Journal of clinical endocrinology and metabolism.

The influence of propranolol on the extrathyroidal metabolism of 3,3',5'-triiodothyronine (reverse T3).

J. Faber, K. Siersbaek-Nielsen, T. Friis, 2009, Acta medica Scandinavica. Supplementum.

Vitamin D metabolism in insulin-dependent diabetes mellitus.

J. Christiansen, H. Parving, A. Andersen, 1983, Metabolic bone disease & related research.

SERUM LEVELS OF T4, T3, REVERSE T3, 3,3′‐DIIODOTHYRONINE AND 3′,5′‐DIIODOTHYRONINE IN OBESITY, BEFORE AND AFTER JEJUNO‐ILEAL BYPASS

J. Faber, H. Klein, C. Kirkegaard, 1981, Clinical endocrinology.

BETA-BLOCKERS IN THYROTOXICOSIS

J. Faber, T. Friis, C. Kirkegaard, 1980, The Lancet.

[Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets].

B. Thorsteinsson, B. Lund, I. B. Lumholtz, 1980, Ugeskrift for laeger.

Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: studies of 3',5'-diiodothyronine metabolism.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1979, The Journal of clinical endocrinology and metabolism.

Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.

B. Thorsteinsson, O. Snorgaard, K. Siersbaek-Nielsen, 1988, Acta endocrinologica.

Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.

A. Balen, I. B. Lumholtz, 2005, Human reproduction.

Consensus statement on the biosafety of urinary-derived gonadotrophins with respect to Creutzfeldt – Jakob disease

A. Balen, I. B. Lumholtz, 2005 .

The extrathyroidal effect of D,L-propranolol on 3,3',5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine kinetics.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1982, The Journal of clinical endocrinology and metabolism.

Assessing Prion Infectivity of Human Urine in Sporadic Creutzfeldt-Jakob Disease

Shu G. Chen, P. Gambetti, M. Puopolo, 2012, Emerging infectious diseases.

Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kinetics.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1978, The Journal of clinical endocrinology and metabolism.

Variations in serum T3, rT3, 3,3'-diiodothyronine and 3',5'-diiodothyronine induced by acute myocardial infarction and propranolol.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1980, Acta endocrinologica.

The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1985, The Journal of clinical endocrinology and metabolism.

Outcome of long-term antithyroid treatment of graves' disease in relation to iodine intake.

K. Siersbaek-Nielsen, J. Hansen, T. Friis, 1977, Acta endocrinologica.

Serum T4 T3 and Reverse T3 During Treatment with Propranolol in Hyperthyroidism, L-T4 Treated Myxedema and in Normal Man

J. Faber, K. Siersbaek-Nielsen, L. Skovsted, 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

The effect of D,L-4-hydroxypropranolol on the thyroxine to 3,5,3'-triiodothyronine conversion in rat renal and liver microsomes.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1984, Acta endocrinologica.

Simultaneous measurement of 3,5-diiodothyronine and 3,5,3'-triiodothyronine turnover kinetics in euthyroid hyperthyroid, and hypothyroid subjects.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1982, The Journal of clinical endocrinology and metabolism.

Simultaneous turnover studies of thyroxine, 3,5,3' and 3,3',5'-triiodothyronine, 3,5-, 3,3'-, and 3',5'- diiodothyronine, and 3'-monoiodothyronine in chronic renal failure.

J. Heaf, K. Kølendorf, J. Faber, 1983, The Journal of clinical endocrinology and metabolism.

Isolation of radioactive iodothyronines for kinetic studies: a comparison of two methods.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1982, Acta endocrinologica.

The bioavailability of thyroxine and 3,5,3'-triiodothyronine in normal subjects and in hyper- and hypothyroid patients.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1985, Acta endocrinologica.

The effect of different sulfonamides on phenytoin metabolism in man.

K. Siersbaek-Nielsen, L. Skovsted, J. Hansen, 2009, Acta medica Scandinavica. Supplementum.

METABOLIC CLEARANCE AND PRODUCTION RATES OF 3,3′‐DIIODOTHYRONINE, 3′,5′‐DIIODOTHYRONINE AND 3′‐MONOIODOTHYRONINE IN HYPER‐ AND HYPOTHYROIDISM

J. Faber, T. Friis, C. Kirkegaard, 1982, Clinical endocrinology.

Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease.

K. Kølendorf, J. Faber, K. Siersbaek-Nielsen, 1981, Acta endocrinologica.

The extrathyroidal conversion of 3,5,3'-triiodothyronine to 3,5-diiodothyronine in patients with liver cirrhosis.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1983, The Journal of clinical endocrinology and metabolism.